Literature DB >> 25853396

Evaluation of choroidal thickness using enhanced depth imaging by spectral-domain optical coherence tomography in patients with pseudoexfoliation syndrome.

F C Eroglu1, L Asena2, C Simsek2, A Kal1, G Yılmaz2.   

Abstract

PURPOSE: To investigate the choroidal thickness using optical coherence tomography in the eyes of patients with unilateral and bilateral pseudoexfoliation syndrome and to compare them with healthy controls.
METHODS: We studied four groups: (1) affected eyes from 30 patients with unilateral PEX syndrome affecting the right eye of 17 patients and the left eye of 13 patients; (2) clinically unaffected eyes of 30 patients with unilateral PEX syndrome; (3) the eyes of 30 patients with bilateral PEX syndrome; and (4) the eyes of 30 normal healthy subjects. Choroidal thickness was evaluated using high-speed, high-resolution enhanced depth imaging by spectral-domain optical coherence tomography. Optical coherence tomography features were compared in all groups using the statistical package SPSS v 15.0.
RESULTS: The mean subfoveal choroidal thicknesses were 237.35±58.01 μm in group 1; 330.75±47.84 μm in group 2; 206.3±86.75 μm in group 3; and 311.8±51.42 μm in group 4. Significant differences in the mean subfoveal choroidal thickness were found between groups 1 and 2 (P<0.001), groups 1 and 4 (P=0.004), groups 2 and 3 (P<0.001), and groups 3 and 4 (P<0.001).
CONCLUSION: In this study, it was observed that clinically affected eyes of patients with PEX syndrome have significantly thinner choroids compared with the clinically unaffected eyes of patients with unilateral PEX syndrome and eyes of healthy controls.

Entities:  

Mesh:

Year:  2015        PMID: 25853396      PMCID: PMC4469666          DOI: 10.1038/eye.2015.34

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  26 in total

1.  Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study.

Authors:  T Hammer; U Schlötzer-Schrehardt; G O Naumann
Journal:  Arch Ophthalmol       Date:  2001-07

2.  Cerebrovascular blood flow velocities in pseudoexfoliation.

Authors:  Nurşen Yüksel; Yonca Anik; Aysun Kiliç; Vlevent Karabaş; Ali Demirci; Yusuf Cağlar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-13       Impact factor: 3.117

3.  Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes.

Authors:  Takamitsu Fujiwara; Yutaka Imamura; Ron Margolis; Jason S Slakter; Richard F Spaide
Journal:  Am J Ophthalmol       Date:  2009-07-09       Impact factor: 5.258

4.  Monolateral pseudoexfoliatio capsulae: a study of choroidal blood flow.

Authors:  G Sibour; C Finazzo; A Boles Carenini
Journal:  Acta Ophthalmol Scand Suppl       Date:  1997

5.  Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems.

Authors:  Lauren Branchini; Caio V Regatieri; Ignacio Flores-Moreno; Bernhard Baumann; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2011-09-23       Impact factor: 12.079

6.  Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography.

Authors:  Varsha Manjunath; Jordana Goren; James G Fujimoto; Jay S Duker
Journal:  Am J Ophthalmol       Date:  2011-06-25       Impact factor: 5.258

7.  Pseudoexfoliation syndrome in eyes with ischemic central retinal vein occlusion. A histopathologic and electron microscopic study.

Authors:  C Cursiefen; T Hammer; M Küchle; G O Naumann; U Schlötzer-Schrehardt
Journal:  Acta Ophthalmol Scand       Date:  2001-10

8.  Enhanced optical coherence tomography imaging by multiple scan averaging.

Authors:  B Sander; M Larsen; L Thrane; J L Hougaard; T M Jørgensen
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

9.  Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease.

Authors:  Angie H C Fong; Kenneth K W Li; David Wong
Journal:  Retina       Date:  2011-03       Impact factor: 4.256

10.  Changes in axial length and choroidal thickness after intraocular pressure reduction resulting from trabeculectomy.

Authors:  Shinichi Usui; Yasushi Ikuno; Sato Uematsu; Yuko Morimoto; Yoshiaki Yasuno; Yasumasa Otori
Journal:  Clin Ophthalmol       Date:  2013-06-13
View more
  7 in total

1.  Genetics, Diagnosis, and Monitoring of Pseudoexfoliation Glaucoma.

Authors:  Niraj Nathan; Rachel W Kuchtey
Journal:  Curr Ophthalmol Rep       Date:  2016-10-11

2.  Evaluation of choroidal thickness in patients with scleroderma.

Authors:  E Coşkun; O Zengin; S Kenan; G Kimyon; K Erdogan Er; S Okumus; A Mesut Onat; I Erbagcı; B Kısacık
Journal:  Eye (Lond)       Date:  2016-01-22       Impact factor: 3.775

Review 3.  Corneal Alterations Associated with Pseudoexfoliation Syndrome and Glaucoma: A Literature Review.

Authors:  Joel R Palko; Owen Qi; Arsham Sheybani
Journal:  J Ophthalmic Vis Res       Date:  2017 Jul-Sep

4.  Assessment of Outer Retinal Remodeling in the Hibernating 13-Lined Ground Squirrel.

Authors:  Benjamin S Sajdak; Brent A Bell; Tylor R Lewis; Gabriel Luna; Grayson S Cornwell; Steven K Fisher; Dana K Merriman; Joseph Carroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-05-01       Impact factor: 4.799

5.  Retinal and Choroidal Vascular Changes in Eyes with Pseudoexfoliation Syndrome: A Comparative Study Using Optical Coherence Tomography Angiography

Authors:  Esat Çınar; Berna Yüce; Fatih Aslan
Journal:  Balkan Med J       Date:  2019-10-09       Impact factor: 2.021

6.  Comparison of macular choroidal thickness in patients with pseudoexfoliation syndrome to normal control subjects with enhanced depth SD-OCT imaging.

Authors:  Sasan Moghimi; Mehdi Mazloumi; Mohammad Karim Johari; Masoud Aghsaie Fard; Rebecca Chen; Robert Weinreb; Kouros Nouri-Mahdavi
Journal:  J Curr Ophthalmol       Date:  2017-07-12

7.  Does Pseudoexfoliation Syndrome Affect the Choroidal Response After Uneventful Phacoemulsification.

Authors:  Fatih Aslan; Çaglar Öktem
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.